Lista de obras -

A large-scale RNAi-based mouse tumorigenesis screen identifies new lung cancer tumor suppressors that repress FGFR signaling

artículo científico publicado en 2014

A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma

artículo científico publicado en 2016

ADAM28: a potential oncogene involved in asbestos-related lung adenocarcinomas

artículo científico

Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma

artículo científico publicado en 2012

CD11a/ICAM-1 blockade combined with IL-2 targeting therapy causes a paradoxical acceleration of type 1 diabetes.

artículo científico publicado en 2017

Common pathogenic mechanisms and pathways in the development of COPD and lung cancer.

artículo científico publicado en 2011

Correction to: Type 1 diabetes susceptibility alleles are associated with distinct alterations in the gut microbiota

artículo científico publicado en 2018

DNA methylation transcriptionally regulates the putative tumor cell growth suppressor ZNF677 in non-small cell lung cancers

artículo científico publicado en 2015

Does miR-1 play a role in malignant pleural mesothelioma development and progression?

artículo científico publicado en 2013

Epigenomic targets for the treatment of respiratory disease

scientific article published on 01 June 2009

Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer.

artículo científico publicado en 2009

Genome-wide CpG island methylation analyses in non-small cell lung cancer patients.

artículo científico publicado en 2012

Genomic Deletion of and Are Useful Markers for Quality Control of Malignant Pleural Mesothelioma (MPM) Primary Cultures

article

KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma.

artículo científico publicado en 2016

Long non coding RNAs (lncRNAs) are dysregulated in Malignant Pleural Mesothelioma (MPM).

artículo científico publicado en 2013

MS4A1 dysregulation in asbestos-related lung squamous cell carcinoma is due to CD20 stromal lymphocyte expression

artículo científico publicado en 2012

MicroRNA-34c is associated with emphysema severity and modulates SERPINE1 expression.

artículo científico publicado en 2014

Progenitor genotyping reveals a complex clonal architecture in a subset of CALR-mutated myeloproliferative neoplasms.

artículo científico publicado en 2017

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma.

artículo científico publicado en 2013

Type 1 diabetes susceptibility alleles are associated with distinct alterations in the gut microbiota

artículo científico publicado en 2018

Whole genome sequencing for lung cancer.

artículo científico publicado en 2012

miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma

artículo científico publicado en 2015

Lista de obras de

A large-scale RNAi-based mouse tumorigenesis screen identifies new lung cancer tumor suppressors that repress FGFR signaling

A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma

ADAM28: a potential oncogene involved in asbestos-related lung adenocarcinomas

Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma

CD11a/ICAM-1 blockade combined with IL-2 targeting therapy causes a paradoxical acceleration of type 1 diabetes.

Common pathogenic mechanisms and pathways in the development of COPD and lung cancer.

Correction to: Type 1 diabetes susceptibility alleles are associated with distinct alterations in the gut microbiota

DNA methylation transcriptionally regulates the putative tumor cell growth suppressor ZNF677 in non-small cell lung cancers

Does miR-1 play a role in malignant pleural mesothelioma development and progression?

Epigenomic targets for the treatment of respiratory disease

Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer.

Genome-wide CpG island methylation analyses in non-small cell lung cancer patients.

Genomic Deletion of and Are Useful Markers for Quality Control of Malignant Pleural Mesothelioma (MPM) Primary Cultures

KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma.

Long non coding RNAs (lncRNAs) are dysregulated in Malignant Pleural Mesothelioma (MPM).

MS4A1 dysregulation in asbestos-related lung squamous cell carcinoma is due to CD20 stromal lymphocyte expression

MicroRNA-34c is associated with emphysema severity and modulates SERPINE1 expression.

Progenitor genotyping reveals a complex clonal architecture in a subset of CALR-mutated myeloproliferative neoplasms.

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma.

Type 1 diabetes susceptibility alleles are associated with distinct alterations in the gut microbiota

Whole genome sequencing for lung cancer.

miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma